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Acute Toxicity of Gasoline and Some Additives
by Elisabeth Reese1'2 and Renate D. Kimbrough3
The acute toxicity of gasoline; its components benzene, toluene, and xylene; and the additives ethanol,
methanol, and methyl tertiary butyl ether are reviewed. All ofthese chemicals are only moderately to mildly
toxic atacute doses. Because oftheirvolatility, these compounds are notextensively absorbed dermally unless
the exposed skin is occluded. Absorption through the lungs and the gastrointestinal tract is quite efficient.
After ingestion, the principal danger for a number of these chemicals, particularly gasoline, is aspiration
pneumonia, which occurs mainly in children. It is currently not clear whether aspiration pneumonia would still
be aproblem ifgasoline weredilutedwithethanol ormethanol. Duringthe normal useofgasoline ormixtures
ofgasoline andtheothersolvents asafuel,exposureswouldbe much lowerthanthedosesthathaveresulted in
poisoning. No acute toxic health effects would occur during the normal course of using automotive fuels.
Introduction
This paper reviews the acute toxicity of gasoline and
some components that have been used as blending agents
in automobile fuels. The data used to prepare this review
were gleaned from laboratory animal studies, human case
reports, and some human studies. In many instances the
exposure levels in experimental animal studies are much
higher than would be encountered by humans from evap-
orative emissions or from contamination ofsoil or ground-
water. Similarly, most of the reports dealing with acute
toxicity of these substances in humans are case reports
where individuals either intentionally or accidentally
ingested large quantities of these chemicals. Tables for
each chemical provide an abbreviated list of dose levels
corresponding to specific health effects. However, only
limited comparisons can be made between various dose
levels listed in these tables due to varying quality of the
experimental data.
Abasic limitation ofthe information on acute toxicity is
thatmost ofthe available data dealwith ingestion. Inhala-
tion is animportant exposure route forevaporativevehicle
emissions or emissions during fueling ofautomobiles. The
effect of aerosols on the respiratory tract has not been
studied in detail. A few human case reports exist where
aspiration of liquid material after ingestion has been a
problem. This type of exposure where liquid material is
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spread throughout the lungs after aspiration is quite
different from the inhalation of low concentrations of
aerosols. Thus, these two types of exposure scenarios
would be quite different, and nocomparisons canbemade.
Becausein someinstancesthemetabolismofthevarious
blending agents, such as methanol, may be different, in
different species, the toxicokinetic parameters in relation
to relevant acute toxicity end points are briefly reviewed.
Understanding the biotransformation of these chemicals
allowsidentification ofuseful animal models forextrapola-
tion to humans.
Discussion oftreatment procedures as well as chemical
interactions is not the intent of this paper. For further
informationonamoredetailedreportonclinicaltoxicology
of methanol and hydrocarbon blends (gasoline) and
methodsoftreatment,thereaderisreferredtoLitovitz(1).
The human health effects of some chemicals (xylene,
toluene, benzene, and methyl tertiary butyl ether) as well
astheirbiotransformation are examined in isolation. How-
ever, gasoline as well as these other components are used
as mixtures. Exposure to such mixtures may be to some
extent atvariancefromexposure toindividual compounds.
In addition, because some components of these mixtures
are more volatile than others, the proportions ofthe com-
position ofvapors may be different from that of gasoline
per se.
Gasoline
Gasoline is also known as petrol (Great Britain), benzin
(Germany), motor spirits, and motor fuel. Gasoline is a
highly flammable, mobile liquid. The boiling point of U.S.
gasoline is 50-200°C (2). The conversion factorfrom parts
per million in air byvolume to milligrams per cubic meter
is 2.967.
Gasoline is used as a fuel, diluent, finishing agent, and
industrial solvent (2). The use ofgasoline as motor fuel isREESE AND KIMBROUGH
addressed here. Automotive gasoline is a complex mixture
of relatively volatile hydrocarbons with or without addi-
tives obtained by blending appropriate refinery streams.
In Europe, and to a lesser extent in the United States,
oxygenated compounds are also part ofgasoline's compo-
nents (3).
It has been reported that one gasoline sample, PS-6
gasoline, contained about 53% paraffins, 5% naphthenes,
36% aromatics, 6% olefins, and less than 1% unknowns by
percent ofweight (4). However, other commercial gasoline
mixtures may have different compositions (3). According
to the International Agency for Research on Cancer
(IARC) (3), the aromatic fractions of gasoline contain
benzene at a range of0-7% volume and typically about 2-
3% volume.
Ethanol and methanol may be added to commercial
gasoline. Gasohol is the name given to a mixture of gas-
oline and ethanol and usually contains 10% ethanol (3);
however, as much as 40% ethanol has been added (5).
Oxygenated compounds such as methyl tertiary butyl
ether (MTBE) and tertiary butyl ether (TBE) are also
blended with gasoline to increase octane numbers in the
United States as well as in Europe (6).
The composition of vapor and liquid gasoline differ.
Gasoline vapor comprises mostly short-chain, lowmolecu-
lar weight, more volatile components (such as the C4/C5
chain light paraffins, which make up about 90%). The
aromatics, which are larger and heavier molecules, are
reduced to about 2% in the vapor phase, primarily as
benzene (7).
Since the introduction of unleaded gasoline in the
mid-1970s, the amount of leaded gasoline sold in the
United States has decreased from 75% of total gasoline
sales in 1975 to 25% in 1985 and to roughly10% in 1990 (8).
New automobiles sold after1975 were equipped with cata-
lytic converters, which precluded the use of leaded gas-
oline. Unleaded gasoline may contain some lead but never
more than 0.013 g/L (3).
Gasoline Exposure ofthe General
Population
Kearney and Dunham (9) measured gasoline vapor
concentrations at ahigh-volume service station for 1 week.
Short-term personal samples collected from self-service
customers while refueling ranged from not detectable to
159 mg/im3. The geometric mean for this range was about
23.7mg/m3. Other sources addressing human exposure to
gasoline report similar levels and vary somewhat with
activity. Based on available literature, NESCAUM (10)
calculated that the average exposure oftotal hydrocarbon
vapors over anunspecifiedtimerangedfrom a meanof134
ppm to 5.4 ppm by volume, depending on whether people
were filling their gas tank, present in a fllling station, or
lived within close proximity to a filling station. Similar
levels are given by Environ (11). Additional information on
related topics is given by Gabele (12), who examined the
exhaust and evaporative emissions from a prototype Gen-
eral Motors Variable Fuel Corsica of various gasoline/
methanol blends, and by Piver (13), who addressed
methods of meeting automotive exhaust emissions stan-
dards ofthe 1970 Clean Air Act.
Groundwater contamination due to leaks from under-
ground storagetanks may occur. Inisolatedinstances this
may result in additional exposure of humans from con-
tamination of well water or evaporation of gasoline into
basements. The concentrations that have been measured
inwellwaterhaveusuallybeenintheparts perbillion (pug/
L) range by weight (10).
The doses or concentrations atwhich acute toxic effects
occur in humans and animals are listed in Table 1 and are
also discussed below. The exposures at which the
described effects occur are much greater than any expo-
sures thatwould occurthrough ingestion ofcontaminated
water orthe inhalation ofgasolinewhile fillingthe tank of
a car or spending time at a filling station. Thus, no acute
toxicity would be expected from this type of exposure.
Acute Toxicity in Humans
Duetogasoline'svariablecomposition, itisonlypossible
to generalize about its acute toxicity. Aromatic hydrocar-
bons are moretoxicthan naphthenes,which are moretoxic
than paraffins (14). This is partly due to the more rapid
absorption of aromatic hydrocarbons (15). In general, the
irritant and toxic effects within a particular group of
compounds increases with increasing molecular weight,
branching, and increasing numbers of double bonds (15).
Inhalation and skin contact are the usual routes of
exposure. Accidental ingestion may also occur. The
amount of gasoline absorbed percutaneously is unknown.
With normal storage and use, gasoline ingestion is an
unlikely event. However, a number of cases are usually
encounteredbyphysicians every year. In adults such cases
Table 1. Acute toxicity ofgasoline.
Species Exposure route Dose levela Effect Reference
Rat Oral 18.85 mL/kg LD.,0 Weaver (32)
Aspiration 0.2 mL Instant death Gerarde (33)
Mouse Inhalation 120,000 mg/m-/5 min Lethal dose Sandmeyer (5)
Rabbit Dermal 5 mL/kg 0% mortality Weaver (32)
Human Oral 20-50 g Toxic to adults Moeschlin (17)
350 g Usual fatal dose for adultsb Sollman (34)
Inhalation 2,250 mg/m1/hr No effects Sandmeyer (5)
3,680 mg/mM/hr Slight dizziness, irritation ofeyes, nose, throat Sandmeyer (5)
8,200 mg/m3/hr Dizziness, mucous membranes, irritation, anesthesia Sandmeyer (5)
'Milligrams per cubic meter are calculated based on a molecular weight of100.
bSusceptibility varies.
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areusuallytheresult ofsiphoning, and in childrenitis the
result of accidental ingestion from unlabeled, incorrectly
labeled, or stored containers (6).
The principal target organ for gasoline toxicity is the
central nervous system (CNS). The systemic effects of
acute exposure are CNS depression and mimic those of
ethanol inebriation. Exposure to gasoline concentrations
results in flushing ofthe face, ataxia, staggering, vertigo,
mental confusion, headaches, blurred vision, slurred
speech, and difficulty swallowing. At high concentrations,
coma and death may result in a few minutes without any
accompanying respiratory struggle or postmortem signs
of anoxia (15). The variation in susceptibility observed in
thefataloraldoserangeforadults (Table1)isexplainedby
the occurrence ofrespiratory aspiration. It was stated in
an early extensive review of gasoline intoxication that
single oral doses ofapproximately 7.5 g/kg or a total dose
of 525 g per person for a 70-kg individual would be fatal
(16). On the other hand, much smaller amounts, if aspi-
rated, may lead to secondary pneumonia with a fatal
outcome. This is particularly a problem in children.
Moeschlin (17) indicates that aspiration ofliquid gasoline
causes pulmonary epithelial damage, hemorrhagic pneu-
monia, and pleurisy. Inhalation of concentrated gasoline
vapors mayalso causepulmonaryhemorrhages, aswell as
early signs ofpleuritic pain and pleuritic effusions.
Local effects caused by ingestion ofundiluted gasoline
include a burning sensation in the mouth, pharynx, and
chest,gastrointestinal (GI)tractirritation,vomiting,colic,
and diarrhea (18). Splash contact with eyes causes only
slight transient corneal epithelial damage (19).
In humans, little information is available on a dose-
response relationship. Inhalation exposure to 2250 mg/m3
(5) did notresult in adverse systemic health effects. In an
earlier study, young male volunteers showed CNS symp-
toms after inhalation exposure to between 2100 and 8400
mg/m3 for 30 min to 1 hr (20). Eye irritation was the only
effectin another studywherevolunteers were exposed for
30 min to about 600,1500, and 3000mg/m3 in air (21). Due
to gasoline's varied composition, no single applicable
Federal standard exists foratmospheric concentrations of
gasoline. As of1990-91, American Conference ofGovern-
mental Industrial Hygienists (ACGIH) (22) adopted a
STEL value (short-term exposure limit) of 1480 mg/m3
based on aromatic hydrocarbon content (2) and a TWA
(time-weighted average) of890 mg/m3. In developing this
TWA, the findings made by Drinker et al. (21) were
considered, but itwas determined that these studies were
conducted with atomized whole gasoline rather than the
more volatile fractions commonly found in gasoline vapor.
It was therefore concluded that a TLV-STEL of1480 mg/
m3 and a TWA of 890 mg/m3 was sufficiently protective
(22,23). However, itis notentirelyclear atwhat concentra-
tions the volatile fraction of gasoline would produce eye
irritation. These data were also reviewed by Runion (24).
Gasoline Sniffing
Somepeoplehavebecomehabituatedtotheinhalation of
gasoline because of its initial euphoric effect. Initially,
symptoms resulting from inhalation of gasoline fumes
range from lightheadedness and mild confusion to a psy-
chosislike state. However, these effects are rapidly fol-
lowed by nausea, vomiting, abdominal pain, agitation, and
anxiety. In addition, hypomania, collapse, and coma may
result (25). According to Sandmeyer (5), gasoline can sen-
sitize the myocardium to the effect of endogenous or
exogenous adrenergics, leading to cardiac arrhythmias.
This may explain the occurrence of sudden death during
sniffing and the deaths of storage tank cleaners who do
not use proper respiratory protection.
For leaded gasoline, organolead compounds contribute
more significantly to toxic effects after a 5- to 7-day
latencyperiod.Organoleadpoisoningcausesabnormaljaw
jerk, hyperactive deep tendon reflexes, stance and gait
abnormalities, and intention tremors. Symptoms of mild
cases of organolead poisoning include headache, fatigue,
anorexia, insomnia, and tenseness. Severe cases are
marked byencephalopathywith psychosis, delirium, cere-
bellar ataxia, seizures, and occasionally coma and death
(26). Inhalation abuse of leaded gasoline is also charac-
terized by increased blood and urine lead levels.
Toxicokinetics
Inhaled gasoline is absorbed fasterthaningested gaso-
lineifaspiration does notoccur(16). Insignificantamounts
of gasoline are absorbed through the skin and are not
associated with characteristic systemic effects (15,17).
Because gasoline's components have different metabolic
pathways, the biotransformation of its key components
and additives are addressed individually.
GasolineAdditives. Tetraethyllead has been used as a
gasolineadditiveinanumberofcountries andisemittedin
small quantities from automobile exhaust. Although it
degrades quickly in the atmosphere, it can be very haz-
ardoustogasolinesniffers.Tetraethylleadisrapidlytaken
up by the nervous system. Its toxicity depends on its
activation in vivo to trialkyl forms. Upon absorption into
the body, it is converted to triethyl lead, diethyl lead, and
inorganic lead (27).
Alternative gasoline fuel additives that may be used or
have been suggested to enhance the octane numberwhen
alkyl lead is completely phased out include manganese
oxide, methyl cyclopentadienyl manganese tricarbonyl
(MMT),ethanol,methanol,MTBE,benzene,andtoluene(25).
Acute Toxicity in Animals
Examples of the acute dermal, oral, and inhalation
toxicity in animals are given in Table 1. The acute toxicity
of a gasoline preparation (API 83-06) has been studied
recently (28). Whole-body exposure of five young adult
male and female rats to vapors of about 5 g/L of heavily
catalyticallyreformednaphthaAmericanPetroleum Insti-
tute (API) #83-06 in air was without adverse effects
duringa4-hrexposure andsubsequent14-dayobservation
period (28).
The acute oraltoxicityin ratsin arecentAPI study(29)
resulted in an estimated oral LD50 in female rats of 4.82
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g/kg and in male rats of 5.80 g/kg body weight when
administered undiluted by gavage. The dermal LD50 in
rabbitswas > 6.0g/kg.Theseresultsindicatethatgasoline
is only mildly toxic at acute doses. The primary dermal
irritation indexin rabbits accordingto the Draize testwas
5.4 for rabbits when the test material was applied
undiluted at 0.5 mL/area to clipped abraded and non-
abraded skin, suggesting that gasoline was moderately
irritating. The primary eye irritation scores were 4.7,1.3,
and 0.0, at 1, 24, and 48 hr after the exposure to 0.1 mL of
undiluted material followed by immediate flushing with
water, suggesting that the material was moderately irri-
tatingandthattheirritation subsidedcompletelywithin48
hr. Ifflushingwas notperformed, someirritation was still
noted 48 hr after exposure. The test material was not a
sensitizer in guinea pigs. Nephrotoxicity has also been
reported in male rats after short-term exposures; how-
ever, because of the formation of high concentrations of
xU2u-globulins, this lesion is irrelevant for humans (30,31).
Recommendations and Areas for Further
Research
Aspiration pneumonia afteringestion greatlyinfluences
the toxicity ofgasoline. It is not clear at what concentra-
tion of gasoline in other media, such as air, water, or
alcohol, this would still be a problem. Information on the
effect of dilute solutions ofgasoline on the lung should be
obtained. Additional tests should be conducted in humans
to determine whether and at what concentrations of the
volatile portion ofgasoline in aireye irritation isproduced.
Ethyl Alcohol
Ethyl alcohol is also known as ethanol, algrain,
anhydrol, ethyl hydrate, ethyl hydroxide, and grain alco-
hol. Ethanol is a clear, colorless, flammable liquid with a
molecular formula of C2H5OH and a molecular weight of
46.07 g/mole, aboiling point of78.5°C, avapor pressure of
44 mm Hg (20°C), and a flash point (closed cup) of 13°C
(14). The conversion factor from parts per million by
volumein airtomilligramspercubicmeteris 1.88. Ethanol
iswidelyused as anindustrial solvent. Gasoholisthe name
given to a gasoline blend with 10% ethanol (35). However,
ethanol's consumption as a component ofintoxicating bev-
erages remains the mostimportant cause ofinjury associ-
ated with ethanol use. Examples of acutely toxic doses in
humans and laboratory animals are given in Table 2.
Acute Toxicity in Humans
Theprincipal targetorganforacute alcoholpoisoningis
the central nervous system, and the primary route of
human exposure is ingestion. Ethanol vapors, even at low
concentrations may cause irritation of the mucous mem-
branes ofthe eyes and respiratorytract. Subjects exposed
to 5000-10,000 ppm (9.4-18.8 g/m3) experienced coughing
and eyeirritation,whichwas notnoticed atconcentrations
below 5000 ppm. At these concentrations in air, subjects
may develop stupor and pronounced sleepiness (36). Eth-
anol is a CNS depressant that induces all stages of anes-
thesia. For an average adult, the fatal ingested dose is
approximately 1 L of 40-55% ethanol (the percentage of
ethanol in whiskey, gin, rum, vodka, or brandy) consumed
within a few minutes (37).
The relationship between symptoms and blood ethanol
levels is imprecise due to widely varying physiological
effects inindividuals with similarblood levels. However, at
approximately 0.05-0.15%, decreased inhibitions, incoor-
dination, slow reaction time, and blurred vision are
observed. Definite visual impairment, slurred speech,
hypoglycemia, and staggering are associated with the
blood level range 0.15-0.3% (37). At blood levels above
0.3%, marked incoordination, stupor, hypoglycemia, con-
vulsions, coma, and death are observed (37). In adults,
coma and death are more typically associated with blood
levels above 0.5% (37). Lethalblood alcohol concentrations
canvaryfrom 0.18 to 0.6%,varyinginverselywiththetime
Table 2. Acute toxicity of ethanol.
Species Exposure rioute
Rat Oral
Inhalation
Mouse
Dog
Oral
Inhalation
Oral
Rabbit Oral
IP injection
IV injection
Human Oral
Inhalation
Dose level
7.8-22.5 mL/kg
24,000 mg/m'
5.5-7.0 mg
55,000 mg/m:
10-15 mL/kg
300-400 mL
12.5 mL/kg
3.5-6.0 g/kg
9.4 g/kg
1.8-6 g/L
0.825-1.1 L/person
2600 mg/mr
9400-13,200 mg/rn:
Effect
LD5( range
Lethal dose
MLD
Lethal dose
Narcosis
Fatal dose-adlt
Lethal dose
MLD range
MLD
Lethal blood-alcohol
conc. range
Fatal dose-avg. adult
Headache, stupor
Headache, stupor
dirowsiness
Reference
Kimura (50)
LoewAy and Von der Heide
(51)
Weese (52)
Lehman and Flury (53)
MacNider (54)
Dreisbach (39)
Munch and Schwartze (55)
Barlow (56)
Lehman and Flury (53)
Kaye and Haag (57)
Gosselin (4.3)
Browning (49)
Browning (49)
Notes
Varies with age
By stomach tube
40% solution by stomach
tube
Consumed < 1 hr; 100%
vol
By stomach tube
40-55% ethanol; wAithin a
few minutes
Individuals without
tolerance
Individuals Nith
tolerance
Abbreviations: IP, intraperitoneal; IV, intravenous; MLD, minimal lethal dose.
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of survival. The blood ethanol level at a particular time
afteringestion depends on the rate ofabsorptionfromthe
gastrointestinal (GI) tract and the rate ofbiotransforma-
tion in the liver. A study by Jones and Jones (40) demon-
strated that the blood ethanol concentration after
equivalent oral dosesishigherinwomenthaninmen, even
with allowance for size differences.
Toxicokinetics
Ethanol is readily absorbed by the GI tract and the
lungs (39), whereas percutaneous absorption is usually
negligible. In two case reports, percutaneous alcohol
intoxication in children was demonstrated (41,42); how-
ever, simultaneous inhalation cannot be totally ruled out.
EthanolisrapidlyabsorbedfromtheGItract,particularly
under fasting conditions. In the fasting state, peak blood
ethanollevels areobtainedin30-60min(37). Uponabsorp-
tioninto thebloodstream, ethanol is distributed according
to the water content of tissues. Approximately 90% of
administered dose is metabolized in the liver (43). Recent
studies indicate that alcohol is also partly oxidized in the
gastric mucosa.
Themetabolism ofethanolinthegastrointestinal tissue
is more effective in men than inwomen and to some extent
serves as a barrier protecting against ethanol's systemic
toxicity (44). This barrier is overcome by large doses of
ingested ethanol. In addition, there appears to be a sub-
stantial amountofindividualvariabilityinthecapacityfor
gastric alcohol oxidation. According to Frezza et al. (45),
the capacity for local ethanol metabolism in the gastroin-
testinal tissue could determine howmuch enters systemic
circulation. Thishypothesisisoffered asanexplanationfor
sex-related differences in blood ethanol concentrations.
Intheliver, ethanolis oxidized to acetaldehyde andthen
to acetic acid. The final biotransformation step involves
the oxidation of acetic acid to carbon dioxide and water:
CH3CH2OH -+ CH3CHO -÷CH3COOH -+ CO2 + H20
Ethanol Acetaldehyde Acetic Acid
Several distinct enzyme-mediated pathways are
involved in the oxidation ofethanol to acetaldehyde in the
liver. The respective enzymes involved include alcohol de-
hydrogenase, catalase, and the microsomal ethanol-
oxidizing system (MEOS), inparticular the P450IIe2 (38).
Acetaldehyde dehydrogenase seems to be the primary
enzyme transforming acetaldehyde to acetate. In humans
thisenzymeislocatedinthecytosoloftheliver; in ratsitis
present in the mitochondria. The resulting acetate is
released from the liver and is oxidized peripherally in
other tissues and in plasma. The oxidation rate ofethanol
to carbon dioxide and water is 100-110 mg/kg/hr (36). This
rate remains constant in a given individual and, within
wide limits, is independent ofthe amount consumed.
Variation in the ethanol oxidation rate exists among
different racial and ethnic groups. Omenn (47) and Zeiner
etal. (48) demonstrated amorerapid conversion ofethanol
to acetaldehyde in Chinese subjects than in Caucasians.
These results were explained by an inherited atypical
alcohol dehydrogenase in the Chinese subjects. Flushed
face, tachycardia, and nauseawere associated with higher
blood acetaldehyde levels in this study. Vesell et al. (46)
examined the effects ofgenetic and environmental factors
on ethanol metabolism in humans. The results indicated
that individual differences in rates ofethanol metabolism
among 28 twins were genetically controlled and that
environmental factors played a negligible role.
Ethanol inebriation in humans is rarely attributed to
inhalation exposure. As with ingestion, the degree of
intoxication upon inhalation varies according to degree of
alcoholtolerance. Forthoseunaccustomedtoalcoholexpo-
sure, headache and slight stupor were produced by expo-
sure to 2600 mg/m3 after 33 min. Exposure ofthose with
alcohol tolerance produced headaches only after a 20-min
exposureto9400mg/m3. Fatigueanddrowsinessoccurred
after a 110-min exposure to 13,200 mg/m3 (49).
Acute Toxicity in Animals
Examples oflethal doses byvarious routes ofexposure
are given in Table2. In dogs, an acute ethanol dose of3-10
g/kg produced respiratory failure and death within 12 hr.
Inagroupofdogsgivena1.25g/kg/hrdose, deathresulted
from cardiac failure and circulatory depression after a
delay of 12 hr (5). All of these doses are comparatively
large. Upon ingestion, symptoms of acute toxicity in ani-
malsinclude ataxia, lack ofresponse to stimuli, absence of
corneal reflex, and narcosis. Exposures by inhalation
resultin slightirritation ofmucousmembranes, excitation
followed by ataxia, drowsiness, prostration, narcosis,
twitching, general paralysis, dyspnea, and occasional
death associated with respiratory failure (5). Ethanol is
nonirritatingtotheskinofanimals,anddermalabsorption
is poor. Ethanol is irritating and eveninjurious to the eyes
inundilutedform,butismuchlessirritatingwhen diluted(5).
Gasohol
Because ethanol exposure through gasohol or ethanol
blended fuel exhaust would be diluted with other fuels,
specifically gasoline, the actual ethanol exposure through
evaporative emissions would be much lower than the
amount associated with the acute toxic effects observed in
experimental animal studies or in humans.
Recommendations and Areas for Further
Research
It should be determined whether aspiration pneumonia
after accidental ingestion of gasohol might represent as
much of a problem as the ingestion ofgasoline per se.
Methyl Alcohol
Methyl alcohol, also known as methanol, wood spirit,
carbinal, wood alcohol, wood naphtha, methylol, Colum-
bian spirit, and colonial spirit, is a colorless, volatile liquid
with amolecular formula ofCH30H. Its molecularweight
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is32.04g/mole,theboilingpointis64.7°C, theflashpointis
12°C, and the vapor pressure is 160 mm Hg at 30°C (14).
The conversion factor from parts per million byvolume in
airtomilligrams percubic meteris 1.31. TheTLV-STEL is
328 mg/m3 (22).
A number of acute toxic exposures occur annually in
humans through intentional or unintentional ingestion of
unlabeled commercial solvents, windshield washing solu-
tions, antifreeze, and alcoholic beverages diluted with
methanol. The mostrecent concern forpotentialmethanol
exposure involves its possible use as a major automotive
fuel in the United States.
Methanol Exposure from Vehicle Emissions
Kavet and Nauss (58) translate vehicle-specific emis-
sions into ambient concentrations ofmethanol vaporinthe
following exposure scenarios: thepersonal garage, traffic,
and public parking garage. There is substantial variation
between evaporative emission concentrations for engines
warming up(idling) andfromhotenginesbeingturnedoff.
Potential methanol exposure varies greatly between
engines meeting emission standards and malfunctioning
engines. For engines meeting emission standards in per-
sonal garages, the evaporative emission ofmethanol vapor
can varyfrom < 2.9mg/m3 to > 50mg/m3. The estimated
ambient methanol concentration among hot engines being
turned off,10% ofwhich aremalfunctioning, wasprojected
byGold and Moulis in 1988 tobe as high as 150mg/m3 (59).
Methanol concentrations for traffic situations are gener-
ally much lower (< 6 mg/m3) than those for garages.
The final exposure scenario involves methanol refueling
at service stations. The EPA estimates that the exposure
concentration range for a typical 3-4 min fill-up would be
33-50 mg/m3 methanol (59). However, all the data on
exposure levels are based on a few measurements, and
further studies are needed to elucidate these findings.
Acute Toxicity in Humans
Routesofexposureformethanolincludeingestion, inha-
lation, and percutaneous absorption. Althoughthe present
discussion is chiefly concerned with potential inhalation
exposure fromvehicle emissions, acute intoxication occurs
mostcommonlyviaingestion oflow-priced, adulterated, or
fortified beverages (60).
Early manifestations of intoxication by ingestion are
similar to those for ethanol. In mild cases of methanol
poisoning, patients complain of headache, dizziness, nau-
sea, lassitude, and slight abdominal pain (60). In more
severe cases, fatigue, stupor, cyanosis, visual impairment
orcomplete blindness, metabolic acidosis, convulsions, and
circulatory collapse are noted. Furthermore, coma and/or
respiratory failure and death may ensue (61). Visual
impairment or complete blindness may be permanent.
Examples offatal doses ofmethanol in humans are listed
inTable3.Theusualfataldose rangeis100-250 rriL (14,62).
However, the minimum dose leading to blindness in the
absence ofmedical treatment is between 4 and 10 mL per
person (60,62). In addition to individual susceptibility,
other factors such as the amount consumed, the amount
absorbed over a given time, and concomitant ethanol
ingestion affect lethality.
After the initial intoxication has subsided, secondary
symptoms often arise following alatentperiod ofhours or
days (62). During the asymptomatic latent period, meth-
anol is transformed in the liver to formaldehyde and
formic acid. Acidosis appears to trigger all late symptoms
of methanol poisoning such as visual disturbances. The
severity of the visual disturbances is proportional to the
intensity of the delayed acidosis (62). Blocking methanol
metabolismpreventstheproduction ofmetabolites toxic to
the visual system (58). Ethanol, which blocks methanol
metabolism, is a very effective antidote and alleviates
acidosis (63).
Table 3. Acute toxicity ofmethyl alcohol.
Species Exposure route Dose level Effect Reference Notes
Rat Oral 7.4-13.0 mL/kg LD50 Kimura (50) Methanol, undiluted, via
straight needle
Inhalation 1307 mg/m' Lethal dose of 16/46 McCord (77) Exposure time = 41 hr
animals
Mouse Oral 10.5-12.0 mg MLD Weese (52) 25% solution, single dose
Dog Oral 6.3 g/kg (100%) LD80 Gilger and Potts (66) Gavage, single dose
Rabbit Oral 18 mL/kg Lethal dose Munch and Schwartze (55) By stomach tube
Monkey Oral 3.0 g/kg Lowest lethal dose Gilger and Potts (66) Single dose via gavage
(32-38 hr)
Inhalation 1310 mg/mi Lethal to 4/11 animals McCord (77) 18 hr/day; total exposure
time = 41 hr
IP injection 4 g/kg LD;,0 Clay et al. (78) 20% solution
Dermal 5 mL/kg Lowest reported lethal McCord (77) Secondary complication:
dose edema
Human Oral 100-250 mL Usual fatal dose range Budavari (14) Susceptibility varies
4 mL Permanentblindness Keeney and Mellinkoff
(60)
0.3-1.0 g/kg Minimum lethal dose Kavet and Nauss (58) Untreated cases
range
Abbreviations: LD.,,,, lethal dose, median; MLD, minimal lethal dose; IP, intraperitoneal.
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Benton and Calhoun (64) determined a latent period of
18-48 hr from ingestion of methanol to onset of visual
disturbances. Furthermore, there appears to be no close
correlation between the severity of symptoms, the quan-
tity of methanol consumed, and blood methanol levels
(60,64). Visual effects ranged from spots before the eyes
(scotomata) to completeblindness. In serious cases, pupils
are dilated and unresponsive to light (60). Other charac-
teristic symptoms associated with visual disturbance
include dimness of vision, hyperemia of the optic nerve
head, inflammation ofganglion cells ofthe retina, atrophy
ofthe optic nerve, congested, edematous retina, and blur-
ring ofoptic disk edges. Without prompt treatment ofthe
intoxication, bilateral blindness may result. Even when
completeblindnessisavoided,residualscotomataarechar-
acteristic. Permanentvisual loss is associated with severe
to moderate retinal edema. Other permanent neurologic
sequelae are less frequent. These include speech difficul-
ties, motor dysfunction with rigidity, spasticity, and hypo-
kinesis.
The American Petroleum Institute made a rough pro-
jection ofthe incidence ofmethanol poisoning, morbidity,
and mortality following the proposed widespread use of
methanol fuels (85 or 100% methanol). Based on the
reported 0.375% methanol mortality rate, thewidespread
use ofmethanol fuels could increase the number ofmeth-
anol fatalities by 195 cases per year up from the current
extrapolated 24 cases per year. Similarly, a dramatic
increaseincasesofblindness andneurologicalimpairment
ispredicted. These considerations necessitate the develop-
ment of innovative technical means to prevent siphoning
and access to this material by small children as well as
education ofthe publicbefore methanol canbeused exten-
sively as a fuel (65).
Acute Toxicity in Animals
Examples of fatal doses of methanol in animals are
listed in Table 3. Different animal species show a wide
variation in sensitivity to methanol poisoning (49). Fur-
thermore, similar to humans, animals within the same
species show varying susceptibility to methanol's toxic
effects (66). This explains the wide dose ranges for some
acute toxic effects listed in Table 3.
The long latent period, relatively high toxicity, acidosis,
and ocular injury observed in humans and subhuman
primates are not seen after intoxication of nonprimate
laboratory animals with methanol such as dogs, rabbits,
rats, and mice. The rhesus and pigtail macaque are the
best animal models for the evaluation of human toxicity.
A similar clinical picture in the rhesus macaque and
humans was observed with respect to toxic dose levels,
general clinical symptoms, ocular pathology, and acidosis.
The monkeys showed no symptoms during the first 24 hr
other than a mild, variable intoxication. In most animals
semicoma occurred shortly before death by respiratory
failure on the second day (66). In contrast, rodents and
dogs exhibit different acute toxic effects. Their clinical
picture is characterized by the early onset of symptoms
such as narcosis, ataxia, hypermotility, and increased
amiability proceeding to a semicomatose-comatose state
and finally death. There is no latent period in these
animals (66).
Comparison oflethal doses fornonhuman primates and
other laboratory animals further establishes the nonhu-
man primate as a bettermodel for human acute methanol
toxicity. The lethal dose for most nonprimate laboratory
animals was 6-10 times the average human lethal dose,
whereas the lethal dose for nonhuman primates is within
the same range (66). Similarly, acidosis studies indicate
that nonhuman primates develop severe acidosis much
more frequently than other laboratory animals (38).
Recentlyattempts havebeenmadetouse smalllaboratory
animals such as the rat and the mouse as experimental
models by blocking the oxidation offormic acid (67).
Toxicokinetics
Methanol is readily absorbed when inhaled or ingested
(43). Following uptake and distribution in the body, a
minor portion of administered methanol is eliminated
either unchanged in exhaled breath or urine. Most meth-
anol, however, is metabolized in the liver. Metabolic clear-
ance accounts for about 90% ofinitially administered low
methanol doses (2 mg/kg) in both nonhuman primates and
rats (68). Although methanol metabolism is a saturable
process, Eells et al. (69) showed that even at very high
doses (1 g/kg) administered to monkeys, 78% was
recovered as exhaled CO2.
In addition to the dominant role ofmetabolism in meth-
anol clearance, metabolism is important because of the
association between methanol's delayed acute toxic effects
and its intermediate metabolites. Unless taken in narcotic
doses, methanol itselfis not considered to be the principal
acute toxicant. The metabolic sequence for methanol in all
mammals is as follows:
Methanol (1) -+ Formaldehyde (2) -+ Formate (3) -*CO2 + H20
(H+)
In rats, rabbits, and guinea pigs, the initial oxidation of
methanol to formaldehyde is mediated by a catalase-
peroxidative system. However, humans and nonhuman
primates oxidize methanol to formaldehyde via alcohol
dehydrogenase (38). Theratesofthisinitialmetabolic step
are similar in nonhuman primates and rats. In the second
step of methanol metabolism, formaldehyde is converted
to formic acid. This step is composed of two reactions.
First, formaldehyde is oxidized to S-formylglutathione, a
process that requires reduced glutathione (GSH) and is
mediated by an NAD-dependent formaldehyde dehydro-
genase. Second, S-formylglutathione is converted to for-
mic acid, catalyzed by thiolase. It remains disputed which
intermediate metabolite, formaldehyde or formic acid, is
responsible for delayed effects of methanol poisoning.
However, recent research shows that formate accumula-
tion in the blood ofmonkeys parallels the development of
ocular disturbances and acidosis, supporting the pre-
sumption that formic acid is the prime suspect for the
delayed effects and the ocular toxicity (66,67).
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A folate-dependent pathway is responsible for meta-
bolizing formic acid in both nonhuman primates and rats.
However, rats use the pathway more efficiently than non-
human primates, thus explaining the species-dependent
nature ofthe acute toxicity ofmethanol. At highmethanol
doses, formate enters the folate-dependent pathway in
humans and nonhuman primates at rates that exceed the
pathway's capacity (58).
In the first reaction of the folate-dependent pathway,
formate forms a complex with tetrahydrofolate (THF).
Subsequently, this complexis converted to 10-formyl-THF
(catalyzed byformyl-THF synthetase) and then to carbon
dioxide (catalyzed byformyl-THF dehydrogenase). There
appears to be a strong association between the efficiency
of formate metabolism and the hepatic concentration of
THF. THF is derived from dietary folic acid and by its
regeneration in the folate pathway. Makar andTephly (70)
determined that rats fed a folate-deficient diet became
acidotic and accumulated formate similar to nonhuman
primates. Adiminished capacity to oxidize formate causes
methanol toxicity in folate-deficient rats.
In addition, there is also a strong correlation between
hepatic THF levels andendogenousfolateregeneration. In
a series ofexperiments, Eells et al. (67,69,71) blocked the
folate feedback loop with nitrous oxide (N20), resulting in
a slowed formate oxidation and increased methanol sen-
sitivity. The extenttowhich N20 slowed formate oxidation
was directlyrelated to the decrease in hepatic THF levels,
demonstrating that THF concentration was the critical
factorintheseexperiments. SubsequentresearchbyBlack
etal. (72) showed thatTHF concentration inmonkeylivers
was 59% of that in rats; the ratio of THF concentrations
was similar to theratio oftheirmaximal formate oxidation
rates. Several human studies show that even methanol
exposures notsaturatingthefolatepathwayproduce small
amounts of formate in blood and urine (73-75). However,
background blood formate levels varied in these studies,
masking subtle differences methanol exposure may have
caused. Although incremental formate accumulation may
not be readily measurable against background levels,
Kavet and Nauss (58) determined that the contribution
from a single, brief methanol exposure (worst-case expo-
sure scenario) is about 4% (0.0082 Mm) ofthebackground
formate level (0.2 Mm).
According to Kavet and Nauss (58), the approximate
methanol dose needed to saturate the folate pathway
wouldbe 210mg/kgfor anindividual with 60%bodywater.
Given this figure, Kavet and Nauss (58) concluded it is
unlikely that the folate pathway would be overwhelmed in
the worst-case scenario described above (single exposure
of 200 mg/m3 for up to 15 min in a garage), since the
estimated body burden would be less than 1 mg/kg. The
same conclusion can be applied to methanol vapor expo-
sures of 50 mg/m3 by filling station attendants who are
exposed for several minutes repeatedly throughout the
day. Filling station attendants could expect an initial body
burden of0.05mg/kgduring a5-minexposureto50mg/m3
at the same ventilation. However, 8-15% ofthe population
in the United States has a low red blood cell folate level
(76), which may make this subpopulation more sensitive.
Recommendations/Areas for Further
Research
If methanol becomes widely used in automotive fuel,
exposure to methanol emissions, although not very high,
would bewidespread. Future research should concentrate
on reducing uncertainty about health effects and about
susceptible subpopulations on marginal diets or indi-
viduals who take medications that are folic acid antago-
nists. Further research examining the relation between
formate concentration and persistence in the blood and
visual impairment would be useful for predicting visual
effects ofvehicular methanol exposure.
Methyl Tertiary Butyl Ether
Methyl tertiary butyl ether (MTBE), or tertiary amyl
ether, is a colorless, flammable liquid with a molecular
weight of 88.15 g/mole and a boiling point of 55.2°C (14).
The conversion factor from parts per million volume to
milligrams per cubic meter is 3.6. MTBE is used to
enhance the octane rating in unleaded gasoline. It was
approved by EPA in 1979 as an octane booster in con-
centrations upto11%. MorerecentlyMTBE hasbeenused
in the United States to increase the oxygen content offuel
and thereby lower carbon monoxide and other hydrocar-
bon emissions. Roughly 20% of the fuels now sold in the
United States contain MTBE as an additive, and it is
anticipatedthattheuse ofMTBE willincrease. Because of
this increase in use, the EPA placed MTBE on the list of
chemicals forpriorityconsideration in thepromulgation of
test rules. In 1987 EPA and the MTBE task force of
industry negotiated a testing consent order for MTBE.
Additional information on the toxicity of this compound
will become available in the future.
Using a fuel with 10% MTBE, the expected amount of
MTBE emitted from the tailpipe would be 2% of the
volatile organic compounds. The expected ambient con-
centration ofMTBE at service stationswould be below3.6
mg/m3 (J. Kneiss, personal communication).
Acute Toxicity in Humans
The major exposure route for MTBE used in gasoline
would be through inhalation (79). However, human expo-
sure to MTBE has primarily been associated with its use
as anexperimentaltherapeutic agentdissolvinggallstones
in the bile duct. The local effects observed upon infusion
into the gallbladder or bile duct include short-term eleva-
tion of liver enzymes, burning abdominal pain, and seda-
tion. Systemic effects include perspiration, transient
hypotension, bradycardia, and somnolence with a distinc-
tive smell ofether in the patient's breath.
Allen et al. (80) indicate that MTBE can be effective in
dissolving cholesterol gallstones rapidly without causing
serious side effects in patients. The gall bladder concen-
trates MTBE withminimal systemic absorption. MTBE is
a powerful lipid solvent. Allen et al. (81) suggest that
intravascular and intrahepatic infusion of substantial
amounts might produce hemolysis or necrosis. Allen et al.
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(80) also suggest that the toxicity of MTBE is similar to
that of diethyl ether, although MTBE is less volatile. The
routes of exposure and the concentrations received from
the use of MTBE in gasoline would be quite different.
Exceptforprovidingqualitativeinformation that suggests
how humans might react to high doses of MTBE, the
information of the clinical use of this material is not
particularly relevant to the evaluation of the toxicity of
MTBE as an additive ingasoline. Forthis usetheroutes of
exposure and the doses received are very different.
Acute Toxicity in Animals
MTBE is acutely only slightly toxic (Table 4). Studying
the acute toxicity ofMTBE alone and in combination with
gasoline in mice and rats via intravenous, intraperitoneal,
subcutaneous, and inhalation routes, Snamprogetti (81)
determined that MTBE was more toxic than gasoline, but
the toxicity ofgasoline was not altered by adding 10-15%
MTBE. Conaway et al. (82) determined that although the
addition of10 or 15% (v/v) MTBE to high-octane premium
gasoline did not increase the acute toxicity of gasoline in
rats and mice, it did lengthen the barbiturate-induced
sleeping time, reduce spontaneous motor activity, and
cause slight disturbances in motor coordination.
Most animal data on MTBE concern rats, but there are
some data on monkeys and mice. According to Kneiss
(personal communication) concentrations of 3610 mg/mi
can produce anesthetic effects that are reversible upon
termination of exposure.
Clinical symptoms observed in rats and mice exposed to
29,000 mg/mi air for 6 hr over 13 consecutive days include
hypoactivity, ataxia, and periocular irritation, decreased
startle and pain reflexes, and decreased muscle tone.
These symptoms were reversible, and no mortality was
observed among the rats and mice (79,81). MTBE is
slightly irritating to the eyes and the mucous membranes
and minimally irritating to the skin (82).
Metabolism
After MTBE exposure, 20-70% is rapidly exhaled
depending on the dose and exposure route. The remaining
MTBE is excreted through the urine. In addition to the
excretion of unchanged MTBE primarily via the lungs,
MTBE is also metabolized. MTBE is oxidized to form
formaldehyde and demethylated to form tertiary butyl
alcohol (TBA). TBAis oxidizedto2-methyl-1,2-propanediol
andax-hydroxyisobutyric acid.ThefractionofTBApresent
with MTBE in exhaled air of animals exposed to MTBE
rangesfrom 0.6 to 4.5%. This fractionvarieswith the dose
administered, route of exposure, and time interval after
exposure. Furthermore, there appears tobe anincreasein
the proportion of TBA in exhaled air with time (84).
Excretion of 2-methyl-1,2-propanediol and a-hydroxyis-
obutyric acid was observed in the urine of rats following
inhalation, oral, and intravenous exposure to MTBE.
Brady (85) studied the metabolism of MTBE by rat
hepatic microsomes. An 18-hr pretreatment with 1-5 mL/
kg MTBE induced liver microsomal pentoxyresorufin-
dealkylase activity50-fold. In addition, pretreatmentwith
monoclonal antibodies againsttheP450isozymeP450IIE1
inhibited MTBE metabolism by 35%. Brady et al. (85)
concluded from these results that MTBE oxidation to
formaldehyde and TBA in vivo and possibly other bio-
chemical effects associated with MTBE exposure are
changed by agents affecting the relative quantities of
cytochrome P450 isozymes.
Savolainen et al. (86) used MTBE to determine that the
oxidation of alcohol and glycol ethers involves the break-
down ofthe etherbond. However, thebiotransformation of
TBA by the monooxygenase complex competed for the
breakdown of the ether. In addition, due to TBA's slow
metabolic breakdown, the alcohol conjugated with
glucuronic acid. Savolainen et al. (86) demonstrated a
linear correlation between the concentration of MTBE in
the brain and the blood ether concentration. The high
lipophilicity ofMTBE could explain its high concentration
infat. Itis notclearwhetherspeciesvariation intherate of
metabolism between methylation and oxidation exist
among species and between high and low doses.
It appears unlikely that MTBE in fuel poses a human
health hazard given calculated inhalation exposures dur-
ing refueling ofless than 3.6 mg/m3.
Aromatic Hydrocarbons: Benzene,
Toluene, and Xylene
Aromatic hydrocarbons are used as industrial raw
materials, solvents, and components of many commercial
Table 4. Acute toxicity of methyl tertiary-butyl ether.
Species Exposure route Dose level Effect Reference Notes
Rat Oial 2,963-3,865 mg/kg LD.() Sivak and Murphy (79) By gavage
body weight
Inhalation 126,000 mg/mr LQ() Conaway et al. (82) 4-hr exposure
65,000 mg/m: LQ)( Sivak and Murphy (79) 5.6 min to death
11,000 mg/m: Occasional anesthesia Conaway et al. (82) 6 hr/day, 5 days/week for
9 days
70 mg/L No deaths occurrled ARCO (86) 4-hr exposure
Rabbit Dermal > 10g/kg LD5(0 Syracuse (83)
Human Infusion via 15 mL Perspiration, Geller et al. (87)
common bile hypotension,
duct to bradycardia, narcosis
duodenum
Abbreviations: LD-51, lethal dose, median; LC50, lethal concentration, 50%.
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and consumerproducts (5). In this report onlytheiruse as
components ofgasolinewill be reviewed. Small amounts of
these chemicals occur naturally in blends of gasoline. In
addition, aromatic rich streams containing these hydro-
carbons are added as blending agents in percent con-
centrations tounleaded gasoline to improve the antiknock
characteristics ofgasoline (88).
These substances can enter the body through all expo-
sure routes. However, percutaneous absorption is too slow
to produce acute systemic effects. McDougal et al. (89)
studied the dermal absorption of a number of solvents in
rats and compared them to human data in the literature.
In rats the absorption was generally two to four times
greater than in humans. In these experiments the shaved
rats were given total body exposure but inhaled fresh air
through respiratoryprotectiondevices. Forbenzene, 0.8%
of the dose was taken up. For toluene and m-xylene, the
skin uptake was slightly greater (3.7 and 3.9%, respec-
tively).Additional information on skinpenetration ofthese
and other chemicals is given by Grandjean (90).
There are few if any well-documented fatal poisoning
casesinhumans. Furthermore, studiessuggestthatliquid
hydrocarbons aspirated into lungs after ingestion could
cause more damage than those absorbed through the
gastrointestinal (GI) tract.Accordingto Gerarde (33), the
oral LD50maybe200timesgreaterthantheintratracheal
LD50. Aspiration ofafraction ofamilliliter ofthese liquid
aromatic hydrocarbons would result in extensive pulmon-
ary edema and hemorrhage. More study is needed on the
hazards of aspirating liquid aromatic hydrocarbons (33).
Exposure to aromatic hydrocarbons via inhalation,
ingestion, and injection produces similar systemic clinical
effects. The exception is respiratory tract irritation and
pulmonary edema, which result from inhalation exposure
or aspiration of ingested material subsequent to reg-
urgitation or gastric lavage (gastric lavage is no longer
widely recommended) (43).
The principal target organ in acute intoxication is the
CNS. The clinical picture after acute administration of
benzene, toluene, or xylene is essentially the same and
occurs in about the same dosage range. At acute doses,
these compounds are only moderately toxic. Although
studies with mixtures of these chemicals have not been
conducted, it is possible that if given as a mixture in
comparable amounts the acute toxicity of the mixture
would not differ. The symptoms reported resemble those
occurringwith ethanol inebriation (43). These symptoms,
which follow lower inhalation or oral exposure levels,
include dizziness, weakness, euphoria, headache, nausea,
vomiting,tightnessinthechest, andstaggering(38). More
severe exposures result in visual blurring, tremors, shal-
low and rapid respiration, ventricular fibrillation, paral-
ysis, unconsciousness, and convulsions (39). In contrast to
aliphatic hydrocarbons where coma is associated with
depressedreflexes, benzeneinduces statesofunconscious-
ness that are associated with hyperactive reflexes such as
tremors, motor restlessness, hypertonia, and jerking or
twitching movements (43).
Direct skin contact with liquids promotes defatting of
the keratin layer, which causes vasodilation, erythema,
and dry and scaly dermatitis (5). Xylenes are more potent
skin irritants than benzene or toluene. Direct eye contact
with liquid or solid aromatic hydrocarbons causes itching,
lacrimation, and irritation. Conjunctivitis and corneal
burns have also been reported (33). Liquid toluene
splashed into the eyes causes corneal burns if untreated
(33). Toluene and benzene vapors irritate the mucous
membranes ofthe respiratory tract. The irritant action of
toluene on skin and mucous membranes is stronger than
that ofbenzene. For all three aromatic hydrocarbons, the
degree of irritation depends on the concentration and
duration ofexposure.
The acutely toxic doses of aromatic hydrocarbons are
listed inTables 5-7.All ofthese chemicals have aloworder
of toxicity unless they are aspirated following ingestion
andvomiting. Humans appeartobemore susceptible than
rodents to the acute oral toxicity of aromatic hydrocar-
bons. According to the Agency for Toxic Substances and
Disease Registry (ATSDR) (91), the dose of benzene
expected to cause death in humans is 100 mg/kg/day (for a
period of up to 14 days) compared to 1000 mg/kg/day for
animals (Table 5).
Acute Toxicity ofSpecific Compounds
Benzene. The molecular formula for benzene is C6H6,
the molecular weight is 78.11 g/mole, the boiling point is
80.10 C,thevaporpressureis100mmHgat26.1°C,andthe
flash pointis -11°C (14). The conversion factor fromparts
per million volume to milligrams per cubic meter is 3.19.
Although the majoreffect ofhigh chronicbenzene expo-
sure is hematopoietic toxicity with resulting anemia, leu-
kopenia, thrombocytopenia, and ultimately leukemia in
someindividuals, themostsensitive targetorganforacute
benzene toxicity is the CNS. The acutely toxic doses are
listed in Table 5. The primary signs of mild benzene
intoxication include dizziness,weakness, headache, eupho-
ria, nausea, vomiting, tightness in the chest, and stagger-
ing (33). Benzene intoxication also produces dyspnea,
vertigo and tinnitus, inebriation, and delirium. More
severe exposure results in visual blurring, tremors, ven-
tricular fibrillation, paralysis, unconsciousness, convul-
sions, and deep anesthesia (5,62,91).
TOxICOKINETICS. Becausebenzeneishighlyvolatile,the
most prevalent route of exposure is by inhalation. In
humans, at concentrations of 160-320 mg/m3 in air for
several hours, 50% is absorbed by the lungs. Benzene
inhaled byhuman subjects at a concentration of0.340 mg/
L for 5 hr resulted in 33-65% body retention, 3.8-27.8%
exhaled unchanged through the lungs, and 0.1-0.2%
excreted in the urine (5). A study ofrespiratory retention
and uptake in humans as a function of time during the
exposure period revealed that absorption was greatest in
thefirst5 min, decreasing to a constant level after30min.
Respiratory retention represents the difference between
respiratoryuptakeandexcretion. Schrenketal. (93)deter-
mined that benzene was rapidly absorbed in the lungs of
dogs. Similar to humans, most absorption occurred early
in the exposure period (during the first 30 min), and
equilibrium was established after several hours. In addi-
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TIble 5. Acute toxicity ofbenzene.'
Species Exposure route Dose level Effect Reference Notes
Rat Oral 1.0-5 g/kg LD50 riange Kimura (50) Varies by age and
str ain
930 mg/kg Lowest lethal dose ATSDR (91)
Inhalation 43,800 mg/mr Lowest lethal dose Drew and Fouts (96) 4-hr exposure
Instillation, lung 0.25 mL Cardiac arrest Gerarde (33)
Mouse Oral 4.7 g/kg LD50 Savchenko (97)
Inhalation 33,000 mg/m3 LC50 Svirbely et al. (98)
77 mg/L Lethal dose Sandmeyer (5) Death in 50 min
IP injection 0.47 g/kg LD5( Sandmeyer (5)
Dog Inhalation 146,000 mg/m' Lethal dose Sandmeyer (5)
Rabbit Inhalation 112,000-1,100,000 mg/min Lethal dose Carpenter et al. (99) Death in 36 min
SC injection 0.10 mL Moderate irritant, Wolf et al. (100)
conjunctiva; transient
corneal injury
Human Oral 128-428 mg/kg Lethal dose range ATSDR (91) 70-kg adult
Inhalation 61,000-64,000 mg/mn' Potentially fatal Gerarde (33) 5-10 min
9,600 mg/m3 Tolerable for 30 min-1 hr Gerarde
Abbreviations: LD50, lethal dose, median; LC5(, lethal concentration, 50%; IP, intraperitoneal; SC, subcutaneous.
aNo datawere found for benzene lethality by dermal exposure in humans or animals.
tion, recent animal studieswith rats and miceindicate that
uptake is inversely proportional to exposure concentra-
tions (91), suggesting that at higher concentrations less of
the chemical is absorbed.
Although no definitive scientific data exist on oral
absorption of benzene in humans, case studies show that
benzene is readily and rapidly absorbed by this route. In
addition, animal studies indicate that almost all of the
ingested benzene is absorbed (91). Parke andWilliams (93)
demonstrated that about 90% of 14C-labeled benzene
administered orally to rabbits was eliminated in exhaled
air and urine.
According to ATSDR (91), information on the acute
dermal toxicity of benzene from dermal exposure is not
available. Dempster et al. (94) investigated the time-effect
relationship of behavioral and hematological changes
resulting from benzene inhalation by mice. Although ben-
zene itself is thought to be responsible for neurotoxic
effects, its hematologic effects are thought to be caused by
metabolites. However, in this experiment, hematological
and specific behavioral changes followed the same time
course upon 6-hr inhalation exposure to 320 mg/m3 ben-
zene. This suggests that benzene metabolites may be
involved in behavioral changes observed in mice. After a
6-hr exposure to 3195-9584 mg/m3, Dempster et al. (94)
also observed changes in neuromuscular function in mice.
The short time period between exposure and effect sug-
gests either a direct effect ofbenzene or rapid conversion
to a sufficient concentration ofmetabolites.
The liver is the primary site of benzene metabolism;
conversion of benzene occurs by mixed-function oxidases
there. Retained benzene is oxidized to phenol, 1,2-
dihydroxybenzene, 1,4-dihydroxybenzene, or 1,2,4-
trihydroxybenzene, cresols, mercapturic, ormuconic acids
andconjugated to sulfate orglucuronide (5). Benzene oxide
is also formed and in turn is transformed to phenol.
Hydroquinone and/or catechol are formedbytheintroduc-
tion of a second hydroxyl group. Finally, the addition of a
third hydroxyl group produces 1,2,4-trihydroxybenzene or
glucuronides and sulfate esters through conjugation reac-
tions. Hydroxylated benzene metabolites may be con-
verted to their corresponding quinones or semiquinones
(95).
Benzene appears to stimulate its own metabolism,
increasing the rate of toxic metabolite formation (91). In
contrast, excess phenol accumulation inhibits microsomal
activity by feedback inhibition (5). In addition, pretreat-
ment with other compounds alters the rate of benzene
metabolism. Benzene metabolism, mediated largely by
mixed-function oxidases in hepatic microsomes, is
increased by 40% in rats and 70% in mice upon phenobar-
bital pretreatment. Pretreatment with toluene inhibits
benzene metabolism. Benzene metabolism is enhanced by
ethanolingestion anddietaryfactors such asfooddepriva-
tion and carbohydrate restriction (91). The metabolism
andelimination ofbenzeneappearstobesimilarinhumans
and animals. Accordingto Sandmeyer (5), metabolism and
elimination of benzene is more rapid in humans than in
dogs.
Toluene. Toluene has a molecular formula of C7H8, a
molecular weight of 92.14 g/mole, a boiling point of
110.62°C, a vapor pressure of 22 mm Hg at 20°C, and a
flash point of4.4°C (closed cup) (14). The conversionfactor
from parts per million volume to milligrams per cubic
meter is 3.76. The TLV-STEL is 565 mg/m3 (22).
The acutely toxic doses in different species are listed in
Table 6. The oral LD50 in rats has been reported to be
about 5 g/kg (range 2.6-7 g/kgbodyweight) depending on
age and strain (50,100,101). The reported LC50 for mice is
about 20,040 mg/m3, compared to 32,800 mg/m3 for rats
(98). Toluene is onlyslightlyirritatingto the skin and eyes
of rabbits (102). In humans, in addition to the systemic
effects already discussed, exposure to toluene at low con-
centrations produces anorexia and prolonged reaction
time. At high concentrations, purpura, paresthesia, visual
disturbances, metabolic acidosis, coma followed by pul-
monary edema, and post-narcotic nervous disturbances
havebeenreported (17,101).Acuteexposures to amounts of
toluene sufficient to produce unconsciousness fail to pro-
duce residual organ damage (33).
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Table 6. Acute toxicity oftoluene.
Species Exposure route Dose level Effect Reference Notes
Rat Oral 5500-6500 mg/kg LD,,o range for the Kimura (50) 1 week observed;
adult rata undiluted; one dose,
straight needle
Inhalation 32,800 mg/rn LC50 Carpenter et al. (110) 4-hr exposure
IP injection 800-1,640 mg/kg LD50 range Sandmeyer (5) Undiluted
Mouse Inhalation 20,040 mg/m3 LC50 Svirbely et al. (98) Exposure time not
reported
Dog Inhalation 2860mggmM No discomfort Carpenter et al. (110) 6 hr
Rabbit Inhalation 132,000-170,000 mg/rn Lethal dose Carpenter et al. (110) 40 min to death
Dermal 14 g/kg LD50 Sandmeyer (5)
Human Inhalation 376.7 mg/mi3 LOAEL; eye irritant Andersson et al. (111) 6-hr exposure
380 mg/M3 NOAEL Von Oettingen et al. (18) 8-hr exposure
750 mg/m3 Uncoordination; Von Oettingen et al. (18)
reaction time
impaired
Dermal 753.4 mg/m3 Paresthesias Von Oettingen et al. (18) 8-hr exposure
Eye 376.7-1883.4 mg/m3 Range for irritant Sandmeyer (5)
Abbreviations: LD50, lethaldosemedian; LC50, lethal concentration,50%; IP,intraperitoneal; LOAEL,lowestobservedadverseeffectlevel; NOAEL,
no observed adverse effect level.
aEffect may be age-dependent; LD50 for 14-day-old rats was much lower.
HABITUATION. Toluene abuse and addiction have been
observed in the general population. Addiction may result
from inhaling glues, paint thinners, fingernail polish
removers, andcleaningfluids (43). Fewstudieshave exam-
ined the acute effects of toluene exposure on tolerant
individuals. Garriott and Petty (103) exposed habituated
subjects to airlevels greaterthan 30mg/L,which is above
the reported fatal concentration range of 10-28 mg/L.
Garriott and Petty (103) observed that these individuals
exhibited no distress and only moderate signs ofintoxica-
tion such as slurred speech, impaired ability to concen-
trate, and slow, unsteady movements. However, Garriott
and Petty (103) attribute this effect only partially to
established tolerance and suggest that the reported fatal
dose range be reexamined. Exposure to toluene through
solvent abuse and glue sniffingusuallyinvolves exposures
to a mixture ofcompounds (91).
ToxIcOKINETICS. Human studies indicate that toluene
is readily absorbed after inhalation (104). Ovrum et al.
(105) demonstrated a high correlation between alveolar
and arterial concentrations of toluene during and after
exposure of humane to 300 mg/m3. Pyykko (106) showed
that toluene is absorbed more rapidly via inhalation expo-
surethanfromoralexposure(15-20mincomparedto3hr).
Dermal absorption is much slower than absorption from
eitherinhalation ororalexposure.The amountabsorbedin
human forearm skin per hourwas 14-23 mg/cm2/hr (104).
In addition, the dermal LD50 value of14 g/kg for rabbits
demonstrates negligible dermal absorption through intact
skin ofanimals (Table 6) (5).
It is not possible to correlate health effects to toluene
levels intissues afterabsorption. However, data showthat
toluene is distributed to lipoidal and highly vascular
tissues such as the brain, liver, kidneys, and blood (104).
Benignus et al. (107), who studied toluene levels in the
blood and brain ofrats during and after exposure to 2167
mg/m3 toluene for up to 4 hr, showed thattoluene levels in
the blood and brain of rats upon inhalation exposure
reached 95% ofthe estimated peaklevels in 53 and 58min,
respectively. Although brain and blood toluene levels did
not rise at significantly different rates, the brain level fell
significantly more rapidlythan theblood level. No studies
were found in which toluene distribution in humans or
animals after oral or dermal exposure were reported.
Microsomal liver enzymes control the first step of
toluene metabolism and its initial conversion to benzyl
alcohol. Pyykko (106) demonstrated that continuous
toluene inhalation of 7,500 mg/mi3 in adult male rats
increasedtheleveloftheseenzymessignificantlyafter12-
24 hr. After exposure, enzyme activity and concentration
ofcytochromes returned to control levels in 1-4 days. This
finding is consistent with time courses of induction after
single-dose exposures tootherdrugs such asphenobarbital.
AstudybyGelleret al. (108) suggests thatthe extent of
detoxification of toluene is sex dependent. In male and
female Sprague-Dawley rats acutely exposed to high con-
centrations of toluene (45,000-136,000 mg/m3), hepatic
levels of alcohol dehydrogenase were significantly
increasedinthefemales.Alcohol dehydrogenase catalyzes
the conversion ofbenzyl alcohol, an intermediate metabo-
lite of toluene, to benzaldehyde. Benzaldehyde is even-
tually converted to hippuric acid, the major urinary
metabolite of toluene (109). Female rats do have an
increased capacity to biotransform toluene (104).
Toluene per se is excreted through exhaled air, and
metabolites are primarily excreted in urine. Two metabo-
lites, hippuric acid and to a lesser extent ortho-cresol in
urine are used to monitor exposure in workers (110). In
nonfatal cases, effects of short-term exposure generally
resolve completely after exposure (104).
Xylene.The molecular formula of xylene is C8H1,o the
molecular weight is 106.17 g/mole, the boiling point is
138.3°C, the vapor pressure is 6 mm Hg at 20°C, and the
flash point is 25-27°C (14). The conversion factor from
parts per million volume to milligrams per cubic meter is
4.33.
There are three forms of xylene: ortho-, meta-, and
para-xylene. Mixed xylene is a mixture of these three
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forms with small amounts ofotherchemicals aswell. Both
human and animal data suggest that mixed xylene and o-,
m-, and p-xylene produce similar effects, although not
necessarily with equal potency.
The acutely toxic doses of xylene are listed in Table 7.
According to Hodge and Sterner's (112) classification sys-
tem oftoxicity, the data on acute oral exposure and inhala-
tion of xylenes show them to be slightly toxic by these
exposure routes (113) (Table 7). Effects specific to xylene
inhalation exposure in humans include nose and throat
irritation, severe lung congestion, pulmonary hemor-
rhages, and edema. Animal data provide evidence for
respiratory irritation as well.
Neurological deficits associated with acute xylene inha-
lation exposure in humans include impaired short-term
memory and alteration in equilibrium or body balance. In
addition, there are cases ofxylene producing a variety of
other symptoms including epileptic seizures, amnesia,
cerebral hemorrhage, and unconsciousness. In instances
of solvent abuse, the instant death that results may be
caused by sensitization ofthe myocardium to epinephrine.
When this occurs, endogenous hormones precipitate sud-
den and fatal ventricular fibrillation or respiratory arrest
and consequent asphyxia. Clinical findings from acute
exposures of workers (not necessarily involving solvent
abuse) toxylenesuggestthatfemales are moresusceptible
to solvent effects (114).
According to Sandmeyer (5), the visual disturbances
observed in humans upon acute xylene exposure are com-
parable to the exaggerated rotary and positional nystag-
mus in the rabbit. Furthermore, xylene may produce
turbidity and severe irritation of the conjunctiva, with
lacrimation and edema.
The neurological effects of xylene are not well under-
stood. Human studies indicate that the first observable
neurological effectis seeninthecentralvestibular system,
which controls equilibrium and body balance. Savolainen
et al. (115) determined that the mean venous blood xylene
concentration in which body balance was impaired in six
human subjects was 29.1 ± 3.2 p,mole/L. Experimental
studies often use rabbits to model body balance effects in
humans. Alternatively, xylene may produce clinical symp-
toms by altering nerve conductivity (113).
Mostvolunteersexposedto2000mg/m3technical-grade
xylene for 15 min had eye irritation and irritation of the
upper airways (115). Ingestion of xylene may lead to
irritation of the gastric mucosa (43). Skin contact with
xylene may cause a burning sensation and reversible
erythema (116), and prolonged exposure may lead to con-
tactdermatitis(117). Inaddition,effects onthekidneysand
liverhavebeenreportedinhumansafteracute exposureto
high levels (119,120).
ToxICOKINETICS. Xylene absorption by the lungs and
the stomach is rapid. However, although absorption after
ingestion is complete, retention by the lungs ranges from
50 to 75%. Physical exercise as well as higher concentra-
tions can increase the amount ofxylene absorbed through
the lungs. Experimental studies on humans indicate that
m-xylene in the vapor or liquid form is absorbed through
the skin. However, dermal absorption of xylene is only a
smallfraction ofthatabsorbed afterinhalation (113). More
specifically, Riihimaki and Pfaffli (120) showed that per-
cutaneous exposure to 2610 mg/m3 xylene vapor for 3.5 hr
correspondedto aninhalation exposureoflessthan43mg/
m3 for the same time period.
Once absorbed, xylene's biotransformation takes place
in the liver or the lungs. The metabolism of xylene is
independent ofthe exposure route, the specific isomer, the
administered dose, or the exposure duration. The flrst
step consists essentially of the oxidation of a side-chain
methyl group by microsomal liver enzymes to toluic acids
(methylbenzoic acids). There is agreement among animal
and human studies that xylene induces liver microsomal
cytochrome P450 similar to phenobarbital. The second
Table 7. Acute toxicity ofxylene.
Species Exposure route Dose level Effect Reference Notes
Rat Oral (gavage) 3500-8600 mg/kg LD50 NTP (122), ATSDR (113) Mixed xylene, in corn oil
and undiluted
Inhalation 28,000-29,000 mg/m3 LC50)( ATSDR (113), Carpenter For mixed xylene, 4 hr
et al. (114)
21,000 mg/m3 LC50 Harper et al. (123) For p-xylene, 4 hr
Mouse Oral (gavage) 5,300-5,600 mg/kg LD5) NTP (122) Sex dependent
Inhalation 23,000 mg/M3 LC5() Bonnet et al. (124) For m-xylene, 6 hr
20,000 mg/mrn LD50 Bonnet et al. (124) For o-xylene, 6 hr
17,000 mg/mr3 LCr50 Bonnet et al. (124) For p-xylene, 6 hr
Eye 1.8 mL/kg LD50( Schumacher (125)
Rabbit Dermal 14.1 mL/kg LD:)o Sandmeyer (5) For in-xylene
Eye 13.8 mg Irritation; corneal injury Sandmeyer (5)
Human Oral 15 mL Potential lethal dose Bonnichsen (126)
Inhalation 860mg/m3 Irritant-eyes, nose, Nelson et al. (127) 3-5-minexposure
throat
>870 mg/M3 Nausea, vomiting, Browning (128)
dizziness,
incoordination, mucous
membrane irritation
43,000 mg/M3 Unconscious, potentially Morley (118)
fatal
Abbreviations: LD53,(, lethal dose, median; LC50, lethal concentration, 50%.
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stepinvolves the conjugation oftoluic acids with glycine to
form toluric acids (methylhippuric acids), the primary
urinary end product. The majority ofxylene metabolites
are readily excreted through urine and are indicators of
workerexposure. Much ofthexylenetakenintothebodyis
excreted within 18 hr after exposure. The shortest
reported time for appearance ofmetabolites in urine is 2
hr. The amount ofmethyl hippuric acid excreted in urine
increases with time, reachingamaximum atthe end ofthe
exposure (104).
The metabolism ofxylene in humans and animals pro-
duces the same end products but in different quantities.
The quantitative difference occurs in the metabolism of
methylbenzoic acid or toluic acid. In humans, methylhip-
puric acid accounts for more than 90% of the absorbed
dose, but in rats given m- orp-xylene by IP injection, the
respective amounts of m- and p-methylhippuric acid
excreted in urine ranged from 49% to 62.6% and 64% to
75% ofthe administered dose. Likewise, the proportion of
administered doses excreted in rabbits as methylhippuric
acids was substantially less than that in humans. The
remaining portion is accounted for by production of
glucuronic acid derivatives formed from conjugation with
glucuronic acid (instead of glycine) or the production of
xylenols byaromatic hydroxylation. Sedivec and Flek (121)
showed that humans given 19 mg/kgxylene excreted only
methylhippuric acid, whereas rabbits given 600 mg/kg
excreted both methylhippuric acid and glucuronic acid
derivatives. These quantitative differences may be
explained by larger doses administered to the rabbits.
Furthermore, the formation of an excess amount of glucu-
ronic acid derivatives in rabbits may represent a secondary
alternative pathway activated when the amount ofglycine
available for conjugation is limited or has been depleted.
This would suggest that the second step conjugation of
toluic acid is the rate-limiting step in humans (113).
This paper was presented at the International Symposium on the
Health Effects of Gasoline sponsored by the American Petroleum
Institute, the Association of Swedish Automobile Manufacturers and
Wholesalers, the Institute for Evaluating Health Risks, the Health
Effects Institute, the Institute of Petroleum, the Japan Automobile
Manufacturers Association, the Motor Vehicle Manufacturers Associa-
tion ofthe U.S., Petroleum Association ofJapan, the U.S. Environmental
Protection Agency, and the Western States Petroleum Association.
Funding for the preparation of this document was provided by the
sponsors ofthe International Symposium.
The authors thank C.H. Drewfortechnical assistance and John Doull,
TobieLitowitz, andJacqueline Smith fortheirreviewofanearlierdraftof
this manuscript.
REFERENCES
1. Litovitz, T. Clinical toxicology of the acute ingestion of methanol/
hydrocarbon blends; a state ofthe art review. American Petroleum
Institute Publication 4524, Washington, DC, 1991.
2. Sittig, M. Handbook of Toxic and Hazardous Chemicals and Car-
cinogens, 2nd ed. NoyesPublications, Park Ridge, NJ, 1984, pp. 470-
471.
3. IARC. IARC Monographs on the Evaluation ofCarcinogenic Risks
to Humans, Vol. 45. Occupational Exposure in Petroleum Refining;
Crude Oil and Major Petroleum Fuels. International Agency for
Research on Cancer, Lyon, 1985.
4. Consolidated Sciences Incorporated. Letterto Dr. EdwardVernotof
the American Petroleum Institute, April 24, 1989, Pasedena, TX.
5. Sandmeyer, E. E. Aromatic hydrocarbons. In: Patty's Industrial
Hygiene and Toxicology, Vol. 2, B, 3rd ed. (C. D. Clayton and F. E.
Clayton, Eds.), Interscience Publishers, New York, 1984, pp. 3384-
3387.
6. Conservation ofClean Air and Waterin Europe. Gasolines. Product
Dossier No. 92/103. Brussels, 1992.
7. Page, N. P., and Mehlman, M. Health effects of gasoline refueling
vapors and measured exposures at service stations. Toxicol. Ind.
Health 5: 869-890 (1989).
8. Energy Information Administration. Dept. Energy, Washington,
DC, Petroleum Supply Monthly, April, 1991.
9. Kearney, C. A., and Dunham, D. B. Gasoline vapor exposures at a
high volume service station. Am. Ind. Hyg. Assoc. J. 47(9): 535-539
(1986).
10. NESCAUM. Air Toxics Committee. Evaluation of the Health
Effects from Exposure to Gasoline and Gasoline Vapors. Northeast
States for Coordinated Air Use Management, Final Report. 1989.
11. Environ Corp. SummaryReport on Individual andPopulation Expo-
sures to Gasoline. Environ Corp., Arlington, VA, 1990.
12. Gabele, P. A. Characterization ofemissions from avariable gasoline/
methanol fueled car.J.AirWaste Manage.Assoc.40:296-304 (1990).
13. Piver, W. T. Potential dilemma: the methods ofmeeting automotive
exhaust emissions standards ofthe Clean Air Act of 1970. Environ.
Health Perspect. 8: 165-190 (1974).
14. Budavari, S.The Merck Index. Merck & Company, Inc., Rahway, NJ,
1989.
15. Ainsworth, R. W. Petrol-vapour poisoning. Br. Med. J. 1: 1547-1548
(1960).
16. Machle, W. Gasoline intoxication. J. Am. Med. Assoc. 117: 1965-1971
(1941).
17. Moeschlin, S. Poisoning: Diagnosis and Treatment. Grune & Strat-
ton, NewYork, 1965, pp. 295-298.
18. von Oettingen, W. F. Poisoning, 2nd ed. W.B. Saunders Co., Phila-
delphia, 1958.
19. Grant,W. M. Toxicology ofthe Eye. Charles C.Thomas, Springfield,
IL, 1962.
20. Drinker, P.,Yaglou, C.P.,andWarren, M. F.Thethreshold toxicityof
gasoline vapor. J. Ind. Hyg. Toxicol. 25: 225-232 (1943).
21. Davis, A., Schafer, L. J., and Bell, Z. G. The effect on human
volunteers of exposure to air containing gasoline vapor. Arch.
Environ. Health 1: 548-554 (1960).
22. ACGIH.Threshold LimitValuesforChemical Substances andPhys-
ical Agents. American Conference of Governmental Industrial
Hygienists, Cincinnati, OH, 1991.
23. McDermott, H. J., and Killiany, S. E., Jr. Quest for a gasoline TLV.
Am. Ind. Hyg. Assoc. J. 39: 110-117 (1978).
24. Runion, H. B. Benzene in Gasoline. Am. Ind. Hyg. Assoc. J. 36: 338-
350 (1975).
25. Grandjean, P., and Grandjean, E. C. Biological Effects of Organo-
Lead Compounds. CRC Press, Boca Raton, FL, 1984, pp. 220-237.
26. Edminster, S. C., and Bayer, M. J. Recreational gasoline sniffing:
acute gasoline intoxication and latent organolead poisoning. J.
Emerg. Med. 3: 365-370 (1985).
27. Jensen, K. A. Short review ofproperties of organolead compounds.
In: Biological Effects ofOrganoLead Compounds (P. Grandjean and
E. C. Grandjean, Eds.) CRC Press, Boca Raton, FL, 1984, pp. 1-4;
97-116.
28. API. Acute Inhalation Toxicity Evaluation of a Petroleum-derived
Hydrocarbon in Rats. API #83-06, Heavily Catalytically Derived
Naphtha. Final Report. American Petroleum Institute. Medical
Research Publications, Washington, DC, 1985.
29. API. Acute Oral Toxicity Study in Rats. Acute Dermal Toxicity
Study in Rabbits. Primary Dermal Irritation Study in Rabbits.
Dermal Sensitization Study in Guinea Pigs. API 83-06, Heavy
Catalytically Reformed Naphtha (CAS 64741-68-0). American
Petroleum Institute, Health and Environmental Science Depart-
ment Report, Washington, DC, 1985.
30. Garg, B. D., Olson, M. J., and Li, L. C. Phagolysosomal alterations
induced by unleaded gasoline in epithelial cells of proximal con-ACUTE TOXICITY OF GASOLINE 129
voluted tubules ofmalerats: effectofdoseandtreatmentduration.J.
Toxicol. Environ. Health 26: 101-118 (1989).
31. Olson, M.J., Johnson, J. T., and Reidy, C.A.Acomparison ofmalerat
and human urinary proteins: implications for human resistance to
hyaline dropletnephropathy. Toxicol. Appl. Pharmacol. 102: 524-536
(1990).
32. Weaver, N. K. Gasoline toxicology: implications for human health.
Ann. N.Y. Acad. Sci. 534: 441-451 (1988).
33. Gerarde, H. W. Toxicological studies on hydrocarbons, IX. The
aspiration hazard andthetoxicityofhydrocarbons andhydrocarbon
mixtures. Arch. Environ. Health 6(3): 329-341 (1988).
34. Sollman, T. A Manual of Pharmacology and Its Application to
Therapeutics and Toxicology, 8th ed. W.B. Saunders Co., Phila-
delphia, 1957, pp. 126-127.
35. Laveskog, A. Gasoline additives: past, present, and future. In:
Biological Effects of Organolead Compounds (P. Grandjean and E.
C. Grandjean, Eds.), CRC Press, Boca Raton, FL, 1984, pp. 5-12.
36. Lester, D., and Greenberg, L. A. The inhalation of ethyl alcohol by
man. Q. J. Stud. Alcohol 12: 167-168 (1951).
37. Gleason, M. N., Gosselin, R. E., Hodge, H. C., and Smith, R. P.
Clinical Toxicology of Commercial Products: Acute Poisoning, 3rd
ed. Williams and Wilkins, Baltimore, MD, 1969, pp. 97-100.
38. Andrews, L. S., and Snyder, R. Toxic effects ofsolvents and vapors.
In: Casarett and Doull's Toxicology: The Basic Science of Poisons,
3rded., (C. D. Klaassen, M. D.Amdur, andJ. Doull, Eds.), Macmillan
Publishing Company, NewYork, 1989, pp. 648-652.
39. Dreisbach, R. H., and Robertson,W. 0. HandbookofPoisoning, 12th
ed. Appleton & Lange, Norwalk, CT, 1987, pp. 170-171.
40. Jones, B. M., and Jones, M. K. Male andfemale intoxication levelsfor
threealcoholdoses ordowomenreallygethigherthanmen?Alcohol.
Tech. Rep. 5: 11-14 (1976).
41. Gimenez, E. R.,Vallejo, N. E., Roy, E., Lis, M., Izurieta, E. M., Rossi,
S., and Capuccio, M. Percutaneous alcohol intoxication. Clin. Toxicol.
1: 39-48 (1968).
42. James, V. C. Acute alcoholic poisoning due to the application of
surgical spirit to the legs. Br. Med. J. 1: 539 (1931).
43. Gosselin, R. E. Clinical Toxicology ofCommercial Products, 5th ed.
Williams and Wilkins, Baltimore, MD, 1984, pp. 166-171.
44. Julkunen, R. J. K., di Padova, C., and Lieber, C. S. First-pass
metabolism of ethanol-a gastrointestinal barrier against the sys-
temic toxicity ofethanol. Life Sci. 37: 567-573 (1985).
45. Frezza, M., di Padova, C., Pozzato, G., Terpin, M., Baraona, E., and
Lieber, C. S. High blood alcohol levels in women. The role of
decreased gastric alcohol dehydrogenase activity and first-pass
metabolism. N. Engl. J. Med. 322(2): 95-99 (1990).
46. Vesell, E. S., Page, J. G., and Passananti, G. T. Genetic and environ-
mental factors affecting ethanol metabolism in man. Clin. Phar-
macol. Ther. 12(2): 192-201 (1971).
47. Omenn, G. S. Genetic investigations of alcohol metabolism and of
alcoholism. Am. J. Hum. Genet. 43: 559-561 (1988).
48. Zeiner, A. R., Paredes, A., and Christensen, H. D. The role of
acetaldehyde in mediating reactivity to an acute dose of ethanol
among different racial groups. Alcoholism 3: 11-18 (1979).
49. Browning, E. Toxicity and Metabolism of Industrial Solvents.
Elsevier, New York, 1965, pp. 329-330.
50. Kimura, E. T. Acute toxicity and limits ofsolvent residue for sixteen
organic solvents. Toxicol. Appl. Pharmacol. 19: 699-704 (1971).
51. Loewy, A., and von der Heide, R. Uber die Aufnahme des Meth-
ylalkohols durch die Atmung. Biochem. Zschr. 65: 230-252 (1914).
52. Weese, H. Vergleichende Untersuchungen uber die Wirksamkeit
und Giftigkeit der Diimpfe niedriger aliphatischer Alkohole. Arch.
Exp. Pathol. Pharmakol. 135: 118-130 (1928).
53. Lehmann, K. B., and Flury, F. Toxicology and Hygiene ofIndustrial
Solvents. Williams and Wilkins, Baltimore, MD, 1943.
54. MacNider, W. B. The acute degenerative changes and changes of
recuperation occurring in the liver from the use of ethyl alcohol. J.
Pharmacol. Exp. Ther. 49: 100-116 (1933).
55. Munch, J. C., and Schwartze, E. W. Narcotic and toxic potency of
aliphatic alcoholsuponrabbits. J. Lab. Clin. Med. 10: 985-996 (1925).
56. Barlow, 0. W. Studies on the pharmacology of ethyl alcohol. J.
Pharmacol. Exp. Ther. 56: 177 (1936).
57. Kaye, S., and Haag, H. B. Terminal blood alcohol concentrations in 94
fatal cases ofacute alcoholism. J.Am. Med.Assoc. 165: 451-452 (1957).
58. Kavet, R., and Nauss, K. M. The toxicity ofinhaled methanol vapors.
Crit. Rev. Toxicol. 21: 21-50 (1990).
59. Gold, M. D., and Moulis, C. E. Effects of emission standards on
vehicle-related ozone, formaldehyde and methanol exposures. In:
Proceedings of the 81st Air Pollution Control Association, Detroit,
MI, 81(2): 30 (1988).
60. Keeney, A. H., and Mellinkoff, S. M. Methyl alcohol poisoning. Ann.
Int. Med. 34: 331-338 (1951).
61. Bennett, I. L., Freeman, H. C., Mitchell, G. L., and Cooper, M. N.
Acute methyl alcohol poisoning: a reviewbased on experiences in an
outbreak of323 cases. Medicine 32: 431-463 (1953)
62. Sollman, T. H. A Manual of Pharmacology and Its Applications to
Therapeutics andToxicology, 8th ed.W.B. Saunders Company,Phila-
delphia, 1957.
63. McCoy, H. G., Cipolle, R. J., Ehlers, S. M., Sawchuck, R. J., and
Zaske, D. E. Severe methanol poisoning. Application of a phar-
macokinetic model for ethanol therapy and hemodialysis. Am. J.
Med. 67: 804-807 (1979).
64. Benton, C. D.,andCalhoun, F.P.,Theoculareffectsofmethyl alcohol
poisoning: report of a catastrophe involving 320 persons. Am. J.
Ophthalmol. 36: 1677-1685 (1953).
65. API. Acute Exposure to Methanol in Fuels: A Prediction of Inges-
tion Incidence and Toxicity. American Petroleum Institute, API
Publication Department, Washington, DC, 1988.
66. Gilger, A. P., and Potts, A. M. Studies on the visual toxicity of
methanol: V. The role of acidosis in experimental methanol poison-
ing. Am. J. Ophthalmol. 39: 63-86 (1955).
67. Eells, J. T., Makar, A. B., Noker, P. E., and Tephly, T. R. Methanol
poisoning and formate oxidation in nitrous oxide treated rats. J.
Pharmacol. Exp. Ther. 217: 57-61 (1981).
68. Opperman, J. A. Aspartane metabolism in animals. In: Aspartame:
PhysiologyandBiochemistry(L.D. SteginkandL.J. Filer,Jr.,Eds.)
Marcel Dekker, New York, 1984, p. 141.
69. Eells, J. T., Black, K. A., Tedford, C. E., and Tephly, T. R. Methanol
toxicity in the monkey; effects of nitrous oxide and methionine. J.
Pharmacol. Exp. Ther. 227: 349-253 (1983).
70. Makar, A. B., and Tephly, T. R. Methanol poisoningVI: role offolic
acid in the production of methanol poisoning in the rat. J. Toxicol.
Environ. Health 2: 1201-1209 (1977).
71. Eells, J.T., Black, K.A., Makar,A. B.,Tedfod, C. E., andTephly,T. R.
Theregulation ofone-carbonoxidationintheratbynitrousoxide and
methionine. Arch. Biochem. Biophys. 219: 316-326 (1982).
72. Black, K.A., Eells, J.T., Noker, P. E., Hawtrey, C.A.,andTephly,T. R.
Roleofhepatictetrahydrofolate inthespecies differenceinmethanol
toxicity. Proc. Natl. Acad. Sci. U.S.A. 82: 3854-3858 (1985).
73. Stegink, L. D. Aspartame metabolism in humans: acute dosing
studies. In:Aspartame: PhysiologyandBiochemistry(L. D. Stegink
and T. J. Filer, Jr., Eds.), Marcel Dekker, NewYork, 1984, p. 509.
74. Baumann, K., and Angerer, J. Occupational chronic exposure to
organic solvents.VI. Formicacidconcentration inblood andurine as
anindicatorofmethanolexposure. Int.Arch.Occup. Environ. Health
42: 241-249 (1979).
75. Heinrich, R., and Angerer, J. Occupational chronic exposure to
organic solvents. X. Biological monitoring parameters for methanol
exposure. Int. Arch. Occup. Environ. Health 50: 341-349 (1982).
76. Senti, R. R., and Pilch, S. M., Eds. Assessment of the Folate
Nutritional Status ofthe U.S. Population Based on DataCollected in
the Second National Health and Nutrition Survey, 1976-1980. Life
Science Research Office, Federation of American Societies for
Experimental Biology, Bethesda, MD, 1984.
77. McCord, C. P. Toxicity ofallyl alcohol. J. Am. Med. Assoc. 98: 2269-
2270 (1932).
78. Clay, K. L., Murphy, K. C., and Watkins, W. D. Experimental
methanol toxicity in the primate. Analysis of metabolic acidosis.
Toxicol. Appl. Pharmacol. 34: 49-61 (1975).
79. Sivak, A., and Murphy, J. Methyl tertiary-butyl ether: acute tox-
icological studies. Presented at the IX International Symposium on
Alcohol Fuels, November 12-15, 1991. ECOFUEL (AgipPetroli
Sector), Milano, Italy, 1991.
80. Allen, M. J., Borody, T. J., Bugliosi, T. F., May, G. R., LaRusso, N. F.,
andThistle, J. L.Rapiddissolutionofgallstonesbymethyltert-butyl
ether: preliminary observations. N. Engl. J. Med. 312(4): 217-220
(1985).130 REESE AND KIMBROUGH
81. Sivak, A., and Murphy, J. Methyl tertiary-butyl ether: acute tox-
icological studies. Presented at the IX International Symposium on
Alcohol Fuels, November 12-15, 1991. ECOFUEL (AgipPetroli
Sector), Milano, Italy, 1991.
82. Conaway, C. C., Schroeder, R. E., and Snyder, N. K. Teratology
evaluation ofmethyl tertiary-butyl etherin rats and mice. J. Toxicol.
Environ. Health 16: 797-809 (1985).
83. Syracuse Research Corp. Information Profiles on Potential Occupa-
tional Hazards: MethylTert-ButylEther. CenterforChemicalHazard
Assessment. Contract No. 210-79-0030m, Syracuse, NY, 1982.
84. Sivak, A., and Murphy, J. Methyl tertiary-butyl ether: acute tox-
icological studies. Presented at the IX International Symposium on
Alcohol Fuels, November 12-15, 1991. ECOFUEL (AgipPetroli
Sector), Milano, Italy, 1991.
85. Brady, J. F, Xiao, F., Ning, S. M., and Yang, C. S. Metabolism of
methyltertiary-butyl etherbyrathepaticmicrosomes.Arch.Toxicol.
64(2): 157-160 (1990).
86. Savolainen, H., Pfaffli, P., and Elovaara, E. Biochemical effects of
methyl tertiary-butyl ether in extended vapour exposure of rats.
Arch. Toxicol. 57: 285-288 (1985).
87. Geller, E., Cronan, J. J., Dorman, G. S., and Rocchio, M. Success of
contact chemolysis in calcified cholesterol gall stones. Rhode Island
Med. J. 72: 7-11 (1989).
88. Hillard, J. H. Gasoline and other motor fuels. In: Gas Conditioning
and Processing, 2nd ed. (J. M. Campbell, Ed.), Norman, OK, 1970,
pp. 652-682.
89. McDougal, J. N., Jerson, G.W., Clewell, H.J., III,Gargas, M. L., and
Andersen, M. E. Dermal absorption of organic chemical vapors in
rats and humans. Fundam. Appl. Toxicol. 14: 299-308 (1990).
90. Grandjean, P. Skin penetration. In: Hazardous Chemicals at Work.
Taylor and Francis, London, 1990.
91. ATSDR. Toxicological Profile for Benzene. Prepared by Oak Ridge
National Laboratoryunder DOE InteragencyAgreement No. 1857-
B026-A1, Agency for Toxic Substances and Disease Registry,
Atlanta, GA, 1989.
92. Schrenk, H. H., Yant, W. P., Pearce, S. J., Patty, F. A., and Sayers, R.
R. Absorption, distribution and elimination of benzene by body
tissues and fluids of dogs exposed to benzene vapor. J. Ind. Hyg.
Toxicol. 23: 20-34 (1941).
93. Parke, D. V., and Williams, R. T. Studies in detoxification. The
metabolism of benzene containing [14C] benzene. Biochem. J. 54:
231-238 (1953).
94. Dempster, A. M., Evans, H. L., and Snyder, C. A. The temporal
relationship between behavioral andhematological effects ofinhaled
benzene. Toxicol. Appl. Pharmacol. 76: 195-203 (1984).
95. Snyder, C. A. Benzene. In: Ethyl Browning's Toxicity and Metabo-
lismofIndustrialSolvents,2nded.,Vol.1. Hydrocarbons (R. Snyder,
Ed.), Elsevier, New York, 1987, pp. 15-24.
96. Drew, R.T., and Fouts, J. R.Thelack ofeffects ofpretreatmentwith
phenobarbitalandchlorpromazine ontheacutetoxicityofbenzenein
rats. Toxicol. Appl. Pharmacol. 27: 183-193 (1974).
97. Savchenko, M. F. Reaktsiia zhivotnykh raznogo vozrasta na
zheludok nektorykh iadov. Gig. Sanit. 32: 31-35 (1967).
98. Svirbely, J. L., Dunn, R. C., and Von Oettingen, W. F. The acute
toxicityofvaporsofcertain solventscontainingappreciable amounts
ofbenzene and toluene. J. Ind. Hyg. Toxicol. 25: 366-373 (1943).
99. Carpenter, C. P, Shaffer, C. B., Weil, C. S., and Smyth, H. F., Jr.
Studies on the inhalation of 1,3-butadiene with a comparison of its
narcoticeffectwithbenzol,toluol, andstyrene.J. Ind.Hyg.26: 69-78
(1944).
100. Wolf, M.A., Rowe,V. K.,McCollister, D. D., Hollingsworth, R. L., and
Oyen, F. Toxicological studies of certain alkylated benzenes and
benzene. Arch. Ind. Health 14: 387-398 (1956).
101. Withey, R. J., and Hall, J. W. The joint toxic action of perchloro-
ethylene with benzene or toluene in rats. Toxicology 4: 5-15 (1975).
102. Fischman, C.M.,andOster,J. R.Toxiceffectsoftoluene: anewcause
ofhigh anion gap metabolic acidosis. J. Am. Med. Assoc. 241: 1713-
1715 (1979).
103. Garriott, J., andPetty, C.S. Deathfrominhalantabuse: toxicological
and pathological evaluation of34 cases. Clin. Toxicol. 16(3): 305-315
(1980).
104. ATSDR.ToxicologicalProfileforToluene.PreparedbyLifeSystems,
Inc. under subcontract to Clement Associates, Inc. under contract
no.205-88-0608. AgencyforToxic Substances and Disease Registry,
Atlanta, GA, 1990.
105. Ovrum, P., Hultenaken, M., and Lindovist, T. Exposure to toluene in
a photgravure printing plant. Scand. J. Work. Environ. Health 4:
237-245 (1978).
106. Pyykko, K.Time-course ofeffects oftoluene onmicrosomalenzymes
in rat liver, kidney and lung during and after inhalation exposure.
Chem.-Biol. Interact. 44: 299-310 (1983).
107. Benignus, V. A., Muller, K. E., Barton, C. N., and Bittikoffer, J. A.
Toluene levels inbloodandbrain ofrats duringandafterrespiratory
exposure. Toxicol. Appl. Pharmacol. 61: 326-334 (1981).
108. Geller, I., Hartmann, R. J.,and Messiha, F. S. Biochemical aspects of
toluene exposure in the rat as a function of sex. Proc West. Phar-
macol. 26: 197-199 (1983).
109. De Rosa, E., Bartolucci, G. B., Sigon, M.,Callegaro, R.,Perbellini, L.,
andBrugnone, F.Hippuric acidandortho-cresol asbiologicalindica-
tors ofoccupational exposure to toluene. Am. J. Ind. Med. 11: 529-
537 (1987).
110. Carpenter, C. P, Geary, D. L., Myers, R. C., Nachreiner, D. J.,
Sullivan, L. J., and King, J. M. Petroleum hydrocarbon toxicity
studies. XIII. Animal and human response to vapors of toluene
concentrate. Toxicol. Appl. Pharmacol. 36: 473-490 (1976).
111. Andersson, I.,Lundqvist, G.R., Molhave, L.,Pederson, 0. F.,Procter,
D. F.,Vaeth,M.,andWyou, D. P. Humanresponse tocontrolledlevels
oftoluene in six-hour exposures. Scand. J. Work. Environ. Health 9:
405-418 (1983).
112. Hodge, H. C., and Sterner, J. H. Tabulation oftoxicity classes. Am.
Ind. Hyg. Q. 10: 93-96 (1949).
113. ATSDR. Toxicological Profile for Total Xylenes. Prepared by Clem-
entAssociates, Inc.undercontractno.205-88-0608. AgencyforToxic
Substances and Disease Registry, Atlanta, GA, 1990.
114. Carpenter, C. P., Kinkead, E. R., Geary, D. J., Jr., Sullivan, T. J., and
King, J. M. Petroleum hydrocarbon toxicity studies. V. Animal and
human response to vapors of mixed xylenes. Toxicol. Appl. Phar-
macol. 33: 543-558 (1975).
115. Savolainen, K., Riihimaki, V., Vaheri, E., and Linnoila, M. Effects of
xylene and alcohol onvestibular andvisual functions in man. Scand.
J. Work Environ. Health 6: 94-103 (1980).
116. Lauwerys, R. R., Dath, T., Lachapelle, J. M., Buchet, J. P., and Roels,
H.Theinfluence oftwo barrier creams onthe percutaneous absorp-
tion ofm-xylene in man. J. Occup. Med. 20: 17-20 (1978).
117. IARC. Monographs on the Evaluation of Carcinogenic Risks to
Humans, Vol. 47. Some Organic Solvents, Resin Monomers, and
Related Compounds, Pigments andOccupational Exposures in Paint
Manufacture and Painting. International Agency for Research on
Cancer, Lyon, 1989, pp. 125-156.
118. Morley, R.Xylenepoisoning: areportononefatalcaseandtwocases
ofrecoveryafterprolonged unconsciousness. Br. Med. J. 3: 442-443
(1970).
119. Bakinson, M. A., and Jones, R. D. Gassings due to methylene
chloride, xylene, toluene and styrene reported to her Majesty's
FactoryInspectorate 1961-1980. Br.J. Ind. Med.42: 184-190(1985)
120. Riihimaki, V., and Pfaffli, P. Percutaneous absorption of solvent
vapors in man. Scand. J. Work. Environ. Health 4(1): 73-85 (1978).
121. Sedivec,V.,andFlek,J.Theabsorption,metabolism, andexcretionof
xylenes in man. Int. Arch. Occup. Environ. Health 37: 205-217
(1976).
122. NTP. Toxicology and Carcinogenesis Studies of Xylenes (Mixed)
(60%m-xylene, 14%p-xylene, 9% o-xylene, and 17% Ethylbenzene)
(CAS no. 1330-20-7) in F344/N rats and B6C3F1 Mice (Gavage
Studies). Technical Report No. 327, National Toxicology Program,
Research Triangle Park, NC, 1986.
123. Harper, C. Drew, R. T., and Fouts, J. R. Benzene and p-xylene: a
comparison of inhalation toxicities and in vitro hydroxylations. In:
Biological Reactive Intermediates. Formation, Toxicity, and
Inactivation. (D. J. Jollow, J. J. Kocsis, R. Snyder, and H. Vanio,
Eds.), Plenum Press, NewYork, 1975, pp. 302-311.
124. Bonnet, P., Raoult, G., and Gradiski, D. Lethal concentration 50 of
main aromatichydrocarbons.Arch. Mal.Prof. Med.Trav. Secur. Soc.
40: 805-810 (1979).
125. Schuhmacher, H., and Grandjean, E. Narkotische Wirksamkeit und
die akute Toxizitat von neun L6sungsmitteln. Arch. Gewerbepath.
Gewerbehyg. 18: 109-119 (1960).ACUTE TOXICITY OF GASOLINE 131
126. Bonnichsen, R. Poisoningbyvolatile compounds. I. Aromatic hydro-
carbons. J. Foren. Sci. 11: 186-204 (1966).
127. Nelson, K. W., Ege, J. F., Ross, M., Woodman, L. E., and Silverman,
L.J.Sensoryresponsetocertainindustrial solventvapors. Ind. Hyg.
Toxicol. 25: 282-285 (1943).
128. Browning, E. Toxicity and Metabolism of Industrial Solvents.
Elsevier, New York, 1965, pp. 329-330.